Intermittent hypoxia exacerbates anxiety in high-fat diet-induced diabetic mice by inhibiting TREM2-regulated IFNAR1 signaling

Ahmad E, Lim S, Lamptey R, Webb DR, Davies MJ. Type 2 diabetes. Lancet. 2022;400:1803–20.

Article  PubMed  Google Scholar 

Jia L, Du Y, Chu L, Zhang Z, Li F, Lyu D, Li Y, Li Y, Zhu M, Jiao H, et al. Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study. Lancet Public Health. 2020;5:e661–71.

Article  PubMed  Google Scholar 

Pouwer F, Nefs G. Anxiety is common and costly in T2DM - why psychology matters. Nat Rev Endocrinol. 2019;15:567–8.

Article  CAS  PubMed  Google Scholar 

Zhu D, Society C. Guideline for the prevention and treatment of type 2 diabetes mellitus in China (2020 edition). Chin J Endocrinol Metabolism. 2021;37:311–98.

Google Scholar 

Luo A, Xie Z, Wang Y, Wang X, Li S, Yan J, Zhan G, Zhou Z, Zhao Y, Li S. Type 2 diabetes mellitus-associated cognitive dysfunction: advances in potential mechanisms and therapies. Neurosci Biobehav Rev. 2022;137:104642.

Article  CAS  PubMed  Google Scholar 

Dutta BJ, Singh S, Seksaria S, Das Gupta G, Singh A. Inside the diabetic brain: insulin resistance and molecular mechanism associated with cognitive impairment and its possible therapeutic strategies. Pharmacol Res. 2022;182:106358.

Article  CAS  PubMed  Google Scholar 

Yang W, Liu M, Tian Y, Zhang Q, Zhang J, Chen Q, Suo L, Chen Y. The increased prevalence of depression and anxiety in T2DM patients associated with blood glucose fluctuation and sleep quality. BMC Endocr Disord. 2022;22:232.

Article  PubMed  PubMed Central  Google Scholar 

Naicker K, Manuel D, Overland S, Skogen JC, Johnson JA, Sivertsen B, Colman I. Population attributable fractions for type 2 diabetes: an examination of multiple risk factors including symptoms of depression and anxiety. Diabetol Metab Syndr. 2018;10:84.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14:88–98.

Article  PubMed  Google Scholar 

Brzecka A, Madetko N, Nikolenko VN, Ashraf GM, Ejma M, Leszek J, Daroszewski C, Sarul K, Mikhaleva LM, Somasundaram SG, et al. Sleep disturbances and cognitive impairment in the course of type 2 Diabetes-A possible link. Curr Neuropharmacol. 2021;19:78–91.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Reutrakul S, Mokhlesi B. Obstructive sleep apnea and diabetes: a state of the Art Review. Chest. 2017;152:1070–86.

Article  PubMed  PubMed Central  Google Scholar 

Shi Y, Guo X, Zhang J, Zhou H, Sun B, Feng J. DNA binding protein HMGB1 secreted by activated microglia promotes the apoptosis of hippocampal neurons in diabetes complicated with OSA. Brain Behav Immun. 2018;73:482–92.

Article  CAS  PubMed  Google Scholar 

Guo X, Shi Y, Du P, Wang J, Han Y, Sun B, Feng J. HMGB1/TLR4 promotes apoptosis and reduces autophagy of hippocampal neurons in diabetes combined with OSA. Life Sci. 2019;239:117020.

Article  CAS  PubMed  Google Scholar 

Du P, Wang J, Han Y, Feng J. Blocking the LncRNA MALAT1/miR-224-5p/NLRP3 Axis inhibits the hippocampal inflammatory response in T2DM with OSA. Front Cell Neurosci. 2020;14:97.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Borst K, Dumas AA, Prinz M. Microglia: Immune and non-immune functions. Immunity. 2021;54:2194–208.

Article  CAS  PubMed  Google Scholar 

Bar E, Barak B. Microglia roles in synaptic plasticity and myelination in homeostatic conditions and neurodevelopmental disorders. Glia. 2019;67:2125–41.

Article  PubMed  Google Scholar 

Hong S, Dissing-Olesen L, Stevens B. New insights on the role of microglia in synaptic pruning in health and disease. Curr Opin Neurobiol. 2016;36:128–34.

Article  CAS  PubMed  Google Scholar 

Filipello F, Morini R, Corradini I, Zerbi V, Canzi A, Michalski B, Erreni M, Markicevic M, Starvaggi-Cucuzza C, Otero K, et al. The Microglial Innate Immune receptor TREM2 is required for synapse elimination and normal brain connectivity. Immunity. 2018;48:979–e991978.

Article  CAS  PubMed  Google Scholar 

Calcagno N, Baufeld C, Madore C, Butovsky O. TREMendous 2 be social. Immunity. 2018;48:842–3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang Y, Lin Y, Wang L, Zhan H, Luo X, Zeng Y, Wu W, Zhang X, Wang F. TREM2 ameliorates neuroinflammatory response and cognitive impairment via PI3K/AKT/FoxO3a signaling pathway in Alzheimer’s disease mice. Aging. 2020;12:20862–79.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kleinberger G, Brendel M, Mracsko E, Wefers B, Groeneweg L, Xiang X, Focke C, Deußing M, Suárez-Calvet M, Mazaheri F, et al. The FTD-like syndrome causing TREM2 T66M mutation impairs microglia function, brain perfusion, and glucose metabolism. Embo j. 2017;36:1837–53.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang S, Sudan R, Peng V, Zhou Y, Du S, Yuede CM, Lei T, Hou J, Cai Z, Cella M, et al. TREM2 drives microglia response to amyloid-β via SYK-dependent and -independent pathways. Cell. 2022;185:4153–e41694119.

Article  CAS  PubMed  PubMed Central  Google Scholar 

McQuade A, Kang YJ, Hasselmann J, Jairaman A, Sotelo A, Coburn M, Shabestari SK, Chadarevian JP, Fote G, Tu CH, et al. Gene expression and functional deficits underlie TREM2-knockout microglia responses in human models of Alzheimer’s disease. Nat Commun. 2020;11:5370.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu M, Liao M, Huang R, Chen C, Tian T, Wang H, Li J, Li J, Sun Y, Wu C, et al. Hippocampal overexpression of TREM2 ameliorates high fat diet induced cognitive impairment and modulates phenotypic polarization of the microglia. Genes Dis. 2022;9:401–14.

Article  CAS  PubMed  Google Scholar 

Fernandez-Ruiz R, Niewold TB. Type I interferons in autoimmunity. J Invest Dermatol. 2022;142:793–803.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lazear HM, Schoggins JW, Diamond MS. Shared and distinct functions of type I and type III interferons. Immunity. 2019;50:907–23.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu F, Wang H, Tian J, Xu H. Down-regulation of ID2-AS1 alleviates the neuronal Injury Induced by 1-Methy1-4-Phenylpyridinium in Human Neuroblastoma Cell Line SH-SY5Y cells through regulating miR-199a-5p/IFNAR1/JAK2/STAT1 Axis. Neurochem Res. 2021;46:2192–203.

Article  CAS  PubMed  Google Scholar 

Butturini E, Boriero D, Carcereri de Prati A, Mariotto S. STAT1 drives M1 microglia activation and neuroinflammation under hypoxia. Arch Biochem Biophys. 2019;669:22–30.

Article  CAS  PubMed  Google Scholar 

Kraeuter AK, Guest PC, Sarnyai Z. The Open Field Test for Measuring Locomotor Activity and Anxiety-Like Behavior. Methods Mol Biol 2019; 1916:99–103.

Wang XT, Xie YQ, Niu Y, Wan BL, Lu YP, Luo QQ, Zhu L. CX3CL1/CX3CR1 signal mediates M1-type microglia and accelerates high-altitude-induced forgetting. Front Cell Neurosci 2023; 17.

Yoshizaki K, Asai M, Hara T. High-Fat Diet enhances Working Memory in the Y-Maze test in male C57BL/6J mice with less anxiety in the elevated plus maze test. Nutrients 2020; 12.

Piatkowska-Chmiel I, Gawronska-Grzywacz M, Popiolek L, Herbet M, Dudka J. The novel adamantane derivatives as potential mediators of inflammation and neural plasticity in diabetes mice with cognitive impairment. Sci Rep 2022; 12.

Zha L, Yu Z, Fang J, Zhou L, Guo W, Zhou J. NLRC3 Delays the Progression of AD in APP/PS1 Mice via Inhibiting PI3K Activation. Oxid Med Cell Longev 2020; 2020:5328031.

Wu XM, Qian C, Zhou YF, Yan YC, Luo QQ, Yung WH, Zhang FL, Jiang LR, Qian ZM, Ke Y. Bi-directionally protective communication between neurons and astrocytes under ischemia. Redox Biol. 2017;13:20–31.

Comments (0)

No login
gif